SCHEMBL21414330

SCHEMBL21414330

CC(C)c1ccc(CN2CCCN(CCO)CC2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HRH3 Q9Y5N1 3/20 0.44
▸ CHKA P35790 3/20 0.41
▸ PRMT5 O14744 1/20 0.41
▸ WDR77 Q9BQA1 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ NCF1 P14598 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20037592 0.96 ALDH1A1 (0.50) ALDH1A1PKMMEN1KMT2AGAA
SCHEMBL12028959 0.89 HRH3 (0.47) ALDH1A1MEN1KMT2AHRH3CHKA
SCHEMBL21414387 0.86 CHKA (0.57) HRH3CHKALMNACA2NCF1
SCHEMBL4547913 0.86 HRH3 (0.50) ALDH1A1HRH3PRMT5WDR77TSHR
SCHEMBL25896863 0.84 HRH3 (0.53) ALDH1A1MEN1KMT2AHRH3TSHR
SCHEMBL21414349 0.84 ALDH1A1 (0.50) ALDH1A1PKMMEN1KMT2AGAA
SCHEMBL17660303 0.83 LMNA (0.50) ALDH1A1MEN1KMT2ANPC1TP53
SCHEMBL22876978 0.83 ALDH1A1 (0.51) ALDH1A1PKMMEN1KMT2AGAA
SCHEMBL18291450 0.82 ALDH1A1 (0.50) ALDH1A1PKMMEN1KMT2AGAA
SCHEMBL20037661 0.82 PRMT5 (0.38) ALDH1A1PKMMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 — — EP disclosed
Send feedback